Home
/ Ipsen
/ Competitors

Ipsen Competitors and Similar CompaniesClear all

Ipsen's competitors and similar companies include Zentiva, Idorsia, Genentech and Cipla.

	Ipsen Ipsen is a biopharmaceutical company.	Zentiva Zentiva is a company that develops and manufactures generic medicines.	Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 1929	Founding Date 2003	Founding Date 2017	Founding Date 1976	Founding Date 1935
Type	Type Public	Type Private	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more	Locations CZ HQ Tallinn, EE Paris, FR Mumbai, IN Milano, IT Milano, IT Rīga, LV see more	Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 5,358	Employees 3,4721% increase	Employees 8007% increase	Employees 18,077	Employees 27,764
Financial
Revenue (est.)	Revenue (est.) €3.7b (FY, 2025)	Revenue (est.) Kč2.3b (FY, 2021)	Revenue (est.) CHF220.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods €659.1m (FY, 2025)	Cost of goods Kč807.2m (FY, 2021)	Cost of goods CHF20.9m (FY, 2025)	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)
Gross profit	Gross profit €3.3b (FY, 2025)	Gross profit Kč1.5b (FY, 2021)	Gross profit CHF214.3m (FY, 2025)	Gross profit N/A	Gross profit ₹195b (FY, 2026)
Net income	Net income €445.1m (FY, 2025)	Net income (Kč831.2m) (FY, 2021)	Net income (CHF111.7m) (FY, 2025)	Net income N/A	Net income ₹38.7b (FY, 2026)
Operating ⚠
Manufacturing Sites	Manufacturing Sites N/A	Manufacturing Sites 4 (Apr, 2023)	Manufacturing Sites N/A	Manufacturing Sites N/A	Manufacturing Sites 46 (FY, 2024)